| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 786,920 | 1,054,607 | 1,431,642 | 1,529,767 | | Cost of Revenue | 741,457 | 909,543 | 1,099,232 | 1,174,196 | | | Gross Profit | 45,463 | 145,064 | 332,410 | 355,571 | | | Operating Expenses | | Research Development | 15,922 | 17,095 | 17,120 | 17,323 | | Selling General and Administrative | 62,158 | 45,928 | 94,861 | 77,361 | | Non Recurring | 9,706 | 24,072 | 28 | (243) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (42,323) | 57,969 | 220,401 | 261,130 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (595) | 876 | 5,146 | 4,527 | | Earnings Before Interest And Taxes | (46,639) | 57,397 | 222,368 | 253,754 | | Interest Expense | 7,075 | 7,410 | 6,081 | 6,705 | | Income Before Tax | (53,714) | 49,987 | 216,287 | 247,049 | | Income Tax Expense | (21,378) | 6,999 | 67,049 | 78,954 | | Minority Interest | (3,721) | (1,448) | (3,179) | (11,903) | | | | Net Income From Continuing Ops | (32,336) | 42,988 | 149,238 | 168,095 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (32,336) | 42,988 | 149,238 | 168,095 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($32,336) | $42,988 | $149,238 | $168,095 |
|
0.29% Nasdaq 
Income Statement
